
EU approves Sanofi's new-generation rabies vaccine VaxRabeo for all ages
Sanofi's new rabies vaccine, VaxRabeo, has been approved by the European Commission for use in all age groups for both pre-exposure and post-exposure prophylaxis. The vaccine, made with advanced Vero cell technology, offers longer shelf life and bett...


